82 related articles for article (PubMed ID: 18670819)
1. Comparison of perianal diseases in HIV-positive patients during periods before and after protease inhibitors use: what changed in the 21st century.
Nadal SR; Manzione CR; Horta SH
Dis Colon Rectum; 2008 Oct; 51(10):1491-4. PubMed ID: 18670819
[TBL] [Abstract][Full Text] [Related]
2. Anorectal pathology in HIV/AIDS-infected patients has not been impacted by highly active antiretroviral therapy.
Gonzalez-Ruiz C; Heartfield W; Briggs B; Vukasin P; Beart RW
Dis Colon Rectum; 2004 Sep; 47(9):1483-6. PubMed ID: 15486744
[TBL] [Abstract][Full Text] [Related]
3. [Anorectal diseases in HIV-positive patients. A prospective study].
Sánchez Valdez G; Vieyra Antero FJ; Peña Ruiz Esparza JP; Villanueva Sáenz E
Rev Gastroenterol Mex; 1998; 63(2):89-92. PubMed ID: 10068734
[TBL] [Abstract][Full Text] [Related]
4. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
5. The management of infectious and noninfectious anorectal complications in patients with leukemia.
North JH; Weber TK; Rodriguez-Bigas MA; Meropol NJ; Petrelli NJ
J Am Coll Surg; 1996 Oct; 183(4):322-8. PubMed ID: 8843260
[TBL] [Abstract][Full Text] [Related]
6. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
7. [Anorectal lesions in HIV-positive patients using highly active antiretroviral therapy].
Retamozo-Palacios M; de Sousa JB; Santos JB
Rev Soc Bras Med Trop; 2007; 40(3):286-9. PubMed ID: 17653462
[TBL] [Abstract][Full Text] [Related]
8. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
Werneck-Silva AL; Prado IB
J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
[TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
10. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
[TBL] [Abstract][Full Text] [Related]
11. Anorectal disease in HIV-infected patients.
Yuhan R; Orsay C; DelPino A; Pearl R; Pulvirenti J; Kay S; Abcarian H
Dis Colon Rectum; 1998 Nov; 41(11):1367-70. PubMed ID: 9823801
[TBL] [Abstract][Full Text] [Related]
12. [Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients].
Ferraro S; Paolillo S; Gargiulo M; Costanzo P; Maggi P; Chirianni A; Chiariello M; Filardi PP
G Ital Cardiol (Rome); 2009 Sep; 10(9):596-601. PubMed ID: 19891251
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus and liver transplantation: our point of view.
Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.
Baekken M; Os I; Sandvik L; Oektedalen O
J Hypertens; 2008 Nov; 26(11):2126-33. PubMed ID: 18854751
[TBL] [Abstract][Full Text] [Related]
15. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
[TBL] [Abstract][Full Text] [Related]
16. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
Voirin N; Routy JP; Smith D; Baratin D; Trépo C; Cotte L; Touraine JL; Livrozet JM; Cooper DA; Ritter J; André P; Vanhems P
HIV Med; 2008 Jul; 9(6):440-4. PubMed ID: 18705761
[TBL] [Abstract][Full Text] [Related]
17. Microbiology of human immunodeficiency virus anorectal disease.
Goldberg GS; Orkin BA; Smith LE
Dis Colon Rectum; 1994 May; 37(5):439-43. PubMed ID: 8181404
[TBL] [Abstract][Full Text] [Related]
18. [Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status].
Rodríguez de Schiavi MS; Scrigni A; García Arrigoni P; Bologna R; Barboni G; Redondo J; Nastri M; Mecikovsky D; Cantisano C; Moreno R; Siciliani D; Lencina M; Luedicke N; Rezzónico G; Torolla JL; López Papucci S; Luis M; Libonati C; Gamba L; Barbarysky J; Pérez Hernández E; Zlatkes R
Arch Argent Pediatr; 2009 Jun; 107(3):212-20. PubMed ID: 19543629
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
